BioPharma Credit (LSE: BPCR)

Last close As at 02/12/2024

0.96

0.00 (0.00%)

Market capitalisation

USD1,258m

Latest Insights

View More

Investment Companies | Review

Biopharma Credit — A quality dividend play with FY22 yield of 12%

Investment Companies | edison tv

BioPharma Credit – executive interview

Investment Companies | Update

Biopharma Credit — New transaction of up to US$50m

Investment Companies | Update

Biopharma Credit — Fully invested after recent transactions

Research

Update

Investment Companies

Biopharma Credit — Fully invested after recent transactions

Update

Investment Companies

Biopharma Credit — Now listed in the Premium Segment of LSE

Review

Investment Companies

BioPharma Credit — Debt investment in a COVID-19 test provider

Review

Investment Companies

Biopharma Credit — Reinvesting proceeds from loan prepayments

Review

Investment Companies

Biopharma Credit — Debt investment in Collegium Pharmaceutical

Review

Investment Companies

Biopharma Credit — High investment volume in H219

Review

Investment Companies

Biopharma Credit — Invests in Epizyme and Akebia

edison tv

Investment Companies

Bitesize briefing – BioPharma Credit

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Investment Companies

Vietnam Holding – Vietnam in the global digital race

thematic

Investment Companies

US small-cap equities – Time to shine?

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free